Nephrotic-range proteinuria and interstitial nephritis associated with the use of a topical loxoprofen patch

Internal Medicine

Volumn 53, Issue 11, 2014, Pages 1131-1135

  Kikuchi, Hiroaki ^a   Aoyagi, Makoto ^a   Nagahama, Kiyotaka ^b   Yajima, Yu ^a   Yamamura, Chisato ^a   Arai, Yohei ^a   Hirasawa, Suguru ^a   Aki, Shota ^a   Inaba, Naoto ^a   Tanaka, Hiroyuki ^a   Tamura, Teiichi ^a  

^a YOKOSUKA KYOSAI HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Nephrotic range proteinuria; Nonsteroidal anti inflammatory drugs; Topical patch

Indexed keywords

ALBUMIN; CREATININE; LORNOXICAM; LOXOPROFEN; PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLPROPIONIC ACID DERIVATIVE;

AGED; ANOREXIA; ARTICLE; BACKACHE; CASE REPORT; DRUG WITHDRAWAL; EDEMA; ELECTRON MICROSCOPY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FUNCTION; LEG EDEMA; MICROSCOPY; MINIMAL BRAIN DYSFUNCTION; MONONUCLEAR CELL; NEPHROTIC RANGE PROTEINURIA; NEPHROTIC SYNDROME; PROTEINURIA; PRURITUS; URINALYSIS; CHEMICALLY INDUCED; DRUG EFFECTS; ECHOGRAPHY; KIDNEY; LIPOID NEPHROSIS; PATHOLOGY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; KIDNEY; NEPHRITIS, INTERSTITIAL; NEPHROSIS, LIPOID; PHENYLPROPIONATES; PROTEINURIA;

EID: 84901784381     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1669     Document Type: Article

References (14)

1. Schlondorff D. Renal complications of non steroidal antiinflammatory drugs. Kidney Int 44: 643-653, 1993.
2. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 310: 563-572, 1984.
3. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106: 13S-23S, 1999.
4. O'Callaghan CA, Andrews PA, Ogg CS. Renal disease and topical non-steroidal drug use. Br Med J 308: 110-111, 1994.
5. Andrews PA, Sampson SA. Topical non-steroidal drugs are systemically absorbed and may cause renal disease. Nephrol Dial Transplant 14: 187-189, 1999.
6. Mazières B. Topical ketoprofen patch. Drugs R D 6: 337-344, 2005.
7. Heyneman CW, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 60: 555-574, 2000.
8. Brewer AR, McCarberg B, Argoff CE. Update on the use of topical NSAIDs for the treatment of soft tissue and musculoskeletal pain: a review of recent data and current treatment options. Phys Sportsmed 38: 62-70, 2010.
9. Alper AB Jr, Meleg-Smith S, Krane NK. Nephrotic syndrome and interstitial nephritis associated with celocoxib. Am J Kidney Dis 40: 1086-1090, 2002.
10. Abraham PA, Keane WF. Glomerular and interstitial disease induced by nonsteroidal anti-inflammatory drugs. Am J Nephrol 4: 1-6, 1984.
11. Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta 351: 31-47, 2005.
12. Hadgraft J, Whitefield M, Rosher PH. Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study. Skin Pharmacol Appl Skin Physiol 16: 137-142, 2003.
13. Sugawara S, Hasegawa S, Naganuma H, Matsuzawa T. Pharmacokinetics study of the hydrogel patch containing loxoprofen sodium (LX-A) following 5 days applications repeated once or twice a day. Rinshou Iyaku (Journal of Clinical Therapeutics & Medicines) 22: 279-292, 2006 (in Japanese, Abstract in English).
14. Naganuma H, Mochizuki Y, Kawahara Y. Study of pharmacokinetics following oral administration of loxoprofen sodium (CS-600) in humans. Rinshou Iyaku (Journal of Clinical Therapeutics & Medicines) 2: 1219-1236, 1986 (in Japanese, Abstract in English).